Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

JMACU

Maxpro Capital Acquisition (JMACU)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:JMACU
DataOraFonteTitoloSimboloCompagnia
10/04/202315:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
31/03/202322:01Edgar (US Regulatory)Annual Report (10-k)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
30/03/202314:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
29/03/202323:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
29/03/202322:25Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
14/02/202322:56Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
13/01/202322:13GlobeNewswire Inc.Maxpro Capital Acquisition Corp. Confirms Additional Funding and Extension of Deadline to Complete Initial Business CombinationNASDAQ:JMACUMaxpro Capital Acquisition Corporation
10/01/202322:32Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
10/01/202322:05GlobeNewswire Inc.Maxpro Capital Acquisition Corp. Announces Extension to Deadline to Complete Business CombinationNASDAQ:JMACUMaxpro Capital Acquisition Corporation
15/11/202214:00GlobeNewswire Inc.Apollomics Inc. Receives FDA Orphan Drug Designation for Vebreltinib (APL-101) for Treatment of Non-Small Cell Lung Cancer with MET Genomic Tumor AberrationsNASDAQ:JMACUMaxpro Capital Acquisition Corporation
14/09/202214:30GlobeNewswire Inc.Apollomics Inc., a Late-Stage Clinical Biopharmaceutical Company to be Listed on Nasdaq Through Business Combination with Maxpro Capital Acquisition Corp.NASDAQ:JMACUMaxpro Capital Acquisition Corporation
14/02/202222:15Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
26/11/202115:00GlobeNewswire Inc.Maxpro Capital Acquisition Corp. Announces the Separate Trading of Its Class A Common Stock and WarrantsNASDAQ:JMACUMaxpro Capital Acquisition Corporation
14/10/202100:03GlobeNewswire Inc.Maxpro Capital Acquisition Corp. Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment OptionNASDAQ:JMACUMaxpro Capital Acquisition Corporation
13/10/202119:10Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:JMACUMaxpro Capital Acquisition Corporation
08/10/202100:41GlobeNewswire Inc.Maxpro Capital Acquisition Corp. Announces Pricing of $90,000,000 Initial Public OfferingNASDAQ:JMACUMaxpro Capital Acquisition Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:JMACU
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network